−0.66EUR
−16.18 MEUR
6.03 MEUR
23.67 M
About MEDIGENE AG NPV
Sector
Industry
CEO
Selwyn Ho
Website
Headquarters
Martinsried
Employees (FY)
86
Founded
1996
ISIN
DE000A1X3W00
FIGI
BBG00NRVXVH8
MediGene AG is a biotechnology company, which engages in developing innovative, complementary treatment platforms that target various types and stages of cancer. It focuses on the development of personalized T-cell based immunotherapies. It operates through the Immunotherapies and Other products segments. The company was founded by Ernst Ludwig Winnacker and Horst Domdey in June 1994 and is headquartered in Martinsried, Germany.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 0QGJ is 1.79 EUR — it has decreased by 11.63% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange MEDIGENE AG NPV stocks are traded under the ticker 0QGJ.
MEDIGENE AG NPV is going to release the next earnings report on Aug 8, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for MEDIGENE AG NPV has a max estimate of 3.00 EUR and a min estimate of 2.35 EUR.
0QGJ earnings for the last quarter are −0.28 EUR whereas the estimation was −0.38 EUR which accounts for 26.32% surprise. Estimated earnings for the next quarter are −0.51 EUR. See more details about MEDIGENE AG NPV earnings.
MEDIGENE AG NPV revenue for the last quarter amounts to 3.06 M EUR despite the estimated figure of 2.50 M EUR. In the next quarter revenue is expected to reach 2.74 M EUR.
Yes, you can track MEDIGENE AG NPV financials in yearly and quarterly reports right on TradingView.
Like other stocks, 0QGJ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDIGENE AG NPV stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 86.00 employees. See our rating of the largest employees — is MEDIGENE AG NPV on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDIGENE AG NPV EBITDA is −15.03 M EUR, and current EBITDA margin is −249.04%. See more stats in MEDIGENE AG NPV financial statements.